Диссертация (1139542), страница 51
Текст из файла (страница 51)
‒ 2009. ‒ V. 123, № 4. ‒P. 735-746.Akinbami L. J., Moorman J. E., Bailey C., al. e. Trends in asthma prevalence, health careuse, and mortality in the United States, 2001–2010. National Center for Health Statistics. //National Center for Health Statistics. ‒ 2012. № 94.Akuthota P., Xenakis J. J., Weller P. F. Eosinophils: offenders or general bystanders inallergic airway disease and pulmonary immunity? // J Innate Immun.
‒ 2011. ‒ V. 3, № 2. ‒P. 113-119.Albano P. M., Ramos J. D. Association of house dust mite-specific IgE with asthma control,medications and household pets. // Asia Pac Allergy. ‒ 2011 ‒V. 1, № 3. ‒ P. 145-151.Aldakheel F. M., Thomas P. S., Bourke J. E., Matheson M. C., Dharmage S. C., Lowe A. J.Relationships between adult asthma and oxidative stress markers and pH in exhaled breathcondensate: a systematic review. // doi: 10.1111/all.12865. [Epub ahead of print] / 2016.Allergen immunotherapy: a practice parameter second update. // J Allergy Clin Immunol.
‒2007. ‒ V. 120, № 3 Suppl. ‒ P. 25-85.Alvarez-Gutiérrez F. J., Medina-Gallardo J. F., Pérez-Navarro P., Martín-Villasclaras J. J.,al. E. Comparison of the Asthma Control Test (ACT) with lung function, levels of exhalednitric oxide and control according to the Global Initiative for Asthma (GINA) // ArchBronconeumol. . ‒ 2010. ‒ V. 46, № 7. ‒ P. 370-7.Ameli F., Brocchetti F., Tosca M. A., Signori A., Ciprandi G. Adenoidal hypertrophy andallergic rhinitis: is there an inverse relationship? // Am J Rhinol Allergy.
. ‒ 2013. ‒ V. 27,№ 1. ‒ P. 5-10.Ameli F., Castelnuovo P., Pagella F., Caligo G., al. e. Nasal endoscopy in asthmaticchildren: clinical role in the diagnosis of rhinosinusitis. // Rhinology. ‒ 2004. ‒ V. 42, № 1.‒ P. 15-18.Anderson S. D. Indirect challenge tests: Airway hyperresponsiveness in asthma: its295158159160161162163164165166167168169170171172173174175176177measurement and clinical significance. // Chest. ‒ 2010.
‒ V. 138, № 2 (Suppl). ‒ P. 25-30.Andreadis A. A., Hazen S. L., Comhair S. A., Erzurum S. C. Oxidative and nitrosativeevents in asthma // Free Radic Biol Med. ‒ 2003. ‒ V. 35, № 3. ‒ P. 213-225.Antczak A., Nowak D., Shariati B., Krol M., Piasecka G., Kurmanowska Z. Increasedhydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate ofasthmatic patients // Eur Respir J. ‒ 1997. ‒ V. 10, № 6. ‒ P. 1235-1241.Anthracopoulos M. B., Karatza A. A., al. e.
Effects of two nebulization regimens on heartrate variability during acute asthma exacebations in children. // J. Asthma. ‒ 2005. ‒ V. 42,№ 4. ‒ P. 273-279.Antus B. Oxidative Stress Markers in Sputum. // Oxidative Medicine and CellularLongevity V. 2016 (2016), Article ID 2930434.Arai Y., Saul J. P., Albrecht P., Hartley L. H., Lilly L. S., Cohen R. J., Colucci W. S.Modulation of cardiac autonomic activity during and immediately after exercise.
// Am JPhysiol. 1989. ‒ V.256, №1Pt2. - P. 132-141.Asthma: still more questions than answers. // The Lancet. ‒ 2008 ‒V. 372, № 9643. ‒ P.1009.ATS. ATS/ERS recommendations for standardized procedures tor the online and offlinemeasurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. // Am J RespirCrit Care Med. ‒ 2005. ‒ V. 171. ‒ P. 912-930.Attanasi M., Consilvio N. P., Rapino D., Nicola M.
D., al. e. Bronchial hyperresponsivenessto mannitol, airway inflammation and Asthma Control Test in atopic asthmatic children. //Arch Med. - 2016. ‒ C. 137-144.Bacharier L. B., Boner A., Carlsen K. H., Eigenmann P. A., Frischer T., Götz M., Helms P.J., Hunt J., Liu A., Papadopoulos N., Platts-Mills T., Pohunek P., Simons F.
E., ValovirtaE., Wahn U., Wildhaber J. H. Diagnosis and treatment of asthma in childhood: aPRACTALL consensus report. // Allergy. ‒ 2008. ‒ V. 63, № 1. ‒ P. 5-34Bachert C., Patou J., Van Cauwenberge P. The role of sinus disease in asthma. // Curr OpinAllergy Clin Immunol. . ‒ 2006. ‒ V. 6, № 1. ‒ P. 29-36.Bacsi A., Pan L. H., Ba X., Boldogh I. Pathophysiology of bronchoconstriction: role ofoxidatively damaged DNA repair. // Curr Opin Allergy Clin Immunol. - 2016. ‒ P. 59-67.Ballard R.
D., Pak J., al. e. Influence of posture and sustained loss of lung volume onpulmonary function in awake asthmatic subjects. // Am. Rev. Respir. Dis. ‒ 1991. ‒ V. 144.‒ P. 499-503.Baraldi E., Carraro S. Exhaled NO and breath condensate // Paediatr Respir Rev. ‒ 2006.
‒V. 7 Suppl 1. ‒ P. S20-S22.Barnes P. J. Feactive oxigen species and airway inflammation. // Free Rad Biol Med. ‒1990. ‒ V. 9. ‒ P. 235-243.Barnes P. J. Theophylline in Chronic Obstructive Pulmonary Disease: New Horizons. //Proceedings of the ATS. ‒ 2005. ‒ V. 2, № 4. ‒ P. 334 - 339.Barnes P. J., Liew F. Y. Nitric oxide and asthmatic inflammation // Immunol Today. ‒ 1995.‒ V. 16, № 3. ‒ P. 128-30.Bateman E.
D., Boushey H. A., Bousquet J., Busse W. W., Clark T. J. H., Pauwels R. A.,Pedersen S. E. Can Guideline-defined Asthma Control Be Achieved?: The Gaining OptimalAsthma ControL Study. // Am. J. Respir. Crit. Care Med. ‒ 2004. № 170. ‒ P. 836-844.Bateman E. D., Bousquet J., Busse W. W., al. e. Stability of asthma control with regulartreatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study.
// Allergy. ‒2008. ‒ V. 63. ‒ P. 932-938.Bender B., Zhang L. Negative affect, medication adherence, and asthma control in children.// J Allergy Clin Immunol. ‒ 2008. ‒ V. 122. ‒ P. 490-495.Bentur L., Mansour Y., Brik R., Eizenberg Y., Nagler R. M. Salivary oxidative stress inchildren during acute asthmatic attack and during remission // Respir Med. ‒ 2006. ‒ V.100, № 7.
‒ P. 1195-1201.296178179180181182183184185186187188189190191192193194195196197198199Berry M. A., Shaw D. E., Green R. H., Brightling C. E., Wardlaw A. J., Pavord I. D. Theuse of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: anobservational study in adults with asthma // Clin Exp Allergy. ‒ 2005.
‒ V. 35, № 9. ‒ P.1175-1179.Bhakta N. R., Woodruff P. G. Human asthma phenotypes: from the clinic, to cytokines, andback again. // Immunol Rev. ‒ 2011. ‒ V. 242, № 1. ‒ P. 220-232.Bianchim M. S., Sperandio E. F., Martinhão G. S., Matheus A. C., et al. Correlationbetween heart rate variability and pulmonary function adjusted by confounding factors inhealthy adults. // Braz J Med Biol Res. - 2016. ‒ C. S0100-879X2016000300702.Billington C. K., Penn R.
B. m3 Muscarinic Acetylcholine Receptor Regulation in theAirway. // Am. J. Resp. Crit. Care Med. ‒ 2002. ‒ V. 26, № 3. ‒ P. 269-272.Bongers T., O'Driscoll B. R. Effects of equipment and technique on peak flowmeasurements. // BMC Pulm Med. . ‒ 2006. ‒ V. 20. ‒ P. 6:14.Boulet L. P., Boulay M. Asthma-related comorbidities.
// Expert Rev. Respir. Med. . ‒ 2011.‒ V. 5, № 3. ‒ P. 377-393.Brand P. L. P. The clinician's guide on monitoring children with asthma. // The clinician'sguide on monitoring children with asthma. / 2013. ‒ C. 119-125.Brand P. L., Roorda R. J. Usefulness of monitoring lung function in asthma // Arch DisChild. ‒ 2003.
‒ V. 88, № 11. ‒ P. 1021-1025.Brandtzaeg P. Immune functions of nasopharyngeal lymphoid tissue.// AdvOtorhinolaryngol. ‒ 2011. ‒ V. 72. ‒ P. 20-24.Brannan J. D. Bronchial hyperresponsiveness in the assessment of asthma control: Airwayhyperresponsiveness in asthma: its measurement and clinical significance.
// Chest. ‒ 2010.‒ V. 138, № 2 Suppl. ‒ P. 11-17.Broekema M., Timens W., Vonk J. M., F. V., al. E. Persisting Remodeling and Less AirwayWall Eosinophil Activation in Complete Remission of Asthma // Am. J. Respir. Crit. CareMed. . ‒ 2011. ‒ V. 183, № 3. ‒ P. 310-316.Buchvald F., Baraldi E., Carraro S., Gaston B., De Jongste J., Pijnenburg M. W., Silkoff P.E., Bisgaard H.
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years //J Allergy Clin Immunol. ‒ 2005. ‒ V. 115, № 6. ‒ P. 1130-1136.Bukstein D., Kraft M., Liu A. H., Peters S. P. Asthma end points and outcomes: what havewe learned? // J Allergy Clin Immunol. ‒ 2006. ‒ V. 118, № 4 Suppl. ‒ P. S1-15.Bush A. Montelukast in paediatric asthma: where we are now and what still needs to bedone? // Paediatr Respir Rev.
‒ 2014. № Dec 11. ‒ P. Online publication.Bush A., Fleming L. Phenotypes of refractory/severe asthma. // Paediatr Respir Rev. ‒ 2011‒V. 12, № 3. ‒ P. 177-181.Bush A., Menzies-Gow A. Phenotypic differences between pediatric and adult asthma. //Proc Am Thorac Soc. ‒ 2009. ‒ V. 6, № 8. ‒ P. 712-719.Busse W. W., Pedersen S., Pauwels R. A., al. e. The Inhaled Steroid Treatment As RegularTherapy in Early Asthma (START) study 5-year follow-up: effectiveness of earlyintervention with budesonide in mild persistent asthma.
// J Allergy Clin Immunol ‒2008. №121. ‒ P. 1167-1174.Caffarelli C., Dascola C. P., Peroni D., al. E. Airway acidification in childhood asthmaexacerbations. // Allergy Asthma Proc. ‒ 2014. ‒ V. 35, № 3. ‒ P. 51-56.Canning B. J., Fischer A. Neural regulation of airway smooth muscle tone // Respir Physiol.‒ 2001. ‒ V. 125, № 1-2. ‒ P. 113-27.Cardinale F., Giordano P., Chinellato I., Tesse R. Respiratory epithelial imbalances inasthma pathophysiology. // Allergy Asthma Proc. ‒ 2013. ‒ V. 34, № 2. ‒ P. 143-149.Carpagnano G.
E., Barnes P. J., Francis J., Wilson N., Bush A., Kharitonov S. A. Breathcondensate pH in children with cystic fibrosis and asthma: a new noninvasive marker ofairway inflammation? // Chest. ‒ 2004. ‒ V. 125, № 6. ‒ P. 2005-2010.Cassano M., Cassano P. A., Luigi M., Gelardi M. Rhino-bronchial syndrome in children:297200201202203204205206207208209210211212213214215216217218pathogenic correlations and clinical-experimental aspects.
// Int J Pediatr Otorhinolaryngol. .‒ 2006. ‒ V. 70, № 3. ‒ P. 507-513.Cazzola M., Segreti A., Calzetta L., Rogliani P. Comorbidities of asthma: currentknowledge and future research needs. // Current opinion in pulmonary medicine. ‒ 2012. ‒V. 10. ‒ P. 10.1097/MCP.0b013e32835b113aChang S., Linderholm A., Franzi L., al. E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
